NON-HODGKINS LYMPHOMA
Clinical trials for NON-HODGKINS LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new NON-HODGKINS LYMPHOMA trials appear
Sign up with your email to follow new studies for NON-HODGKINS LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise for Hard-to-Treat lymphoma
Disease control OngoingThis study tests a combination of three drugs (glofitamab, atezolizumab or polatuzumab vedotin, plus a pre-treatment of obinutuzumab) in adults with B-cell non-Hodgkin lymphoma that has come back or not responded to prior treatments. The goal is to find the safest dose and see if…
Matched conditions: NON-HODGKINS LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 06, 2026 16:02 UTC
-
New lymphoma cocktail shows promise in early japanese trial
Disease control OngoingThis study tests the safety and effectiveness of a drug called tafasitamab, given alone or combined with other medicines (lenalidomide, parsaclisib, or R-CHOP), in Japanese adults with Non-Hodgkin lymphoma. About 72 participants with relapsed or untreated disease will receive dif…
Matched conditions: NON-HODGKINS LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Incyte Biosciences Japan GK • Aim: Disease control
Last updated May 06, 2026 16:01 UTC
-
Scientists seek blood samples to unlock cancer secrets
Knowledge-focused ENROLLING_BY_INVITATIONThis study collects blood and bone marrow samples from 550 people with blood cancers like leukemia and lymphoma. Researchers will study the samples in the lab to learn more about how these cancers work and find new ways to treat them. Participants only give samples when already n…
Matched conditions: NON-HODGKINS LYMPHOMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 17, 2026 04:29 UTC